Cigna Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Cigna Investments’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,905	Closed	-$210K	–	937
2017 Q4	$210K	Sell	3,905 -200	-5%	-$10.9K	0.01%	827
2017 Q3	$235K	Sell	4,105 -54	-1%	-$3.16K	0.02%	765
2017 Q2	$250K	Buy	+4,159	New	+$237K	0.02%	691

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Cigna Investments's BIVV Position: Q1 2018 in Review

Cigna Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 3,905 shares — an estimated $210K sold.

Cigna Investments first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $250K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Cigna Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Cigna Investments sold 3,905 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $210K.
Cigna Investments first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Cigna Investments's Bioverativ Inc. Common Stock position peaked at $250K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Cigna Investments's 13F filing for Q1 2018, filed 9 May 2018.